Plain-English translation of NCT06867484 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether it's safe to give radiation therapy a second time to people whose breast cancer has come back in the same breast after previous treatment. The study focuses on a targeted type of radiation called Partial Breast Irradiation (PBI), which treats only the area where the cancer returned rather than the whole breast. Researchers want to understand both the benefits and any potential side effects of this approach.
When breast cancer comes back in the same breast after previous radiation therapy, doctors face a difficult choice: giving radiation again might help prevent the cancer from returning, but it could also cause side effects to surrounding healthy tissue. This trial exists to learn whether the new treatment is safe and effective enough to become a standard option for patients in this situation.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive targeted radiation therapy focused on the area where your cancer returned. The exact schedule and number of radiation sessions will be determined by your medical team based on your specific situation. You will have follow-up visits to check how you are doing and to monitor for any side effects from the treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States